<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260613069777N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-08-17</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of exercises with blood flow restriction on pain, muscle strength and function in people with osteoarthritis</public_title>
      <acronym></acronym>
      <scientific_title>The effect of closed and open kinetic chain exercises combined with blood flow restriction therapy on pain, muscle strength, and function in patients with knee osteoarthritis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-09-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/92255</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants will be randomly allocated to two intervention groups in a 1:1 ratio using a computer-generated random sequence. Randomization will be performed using Random Allocation Software. Gender matching will be considered to ensure balanced distribution of male and female participants between the two groups. Allocation concealment will be maintained using sequentially numbered, sealed, opaque envelopes, Blinding description: The outcome assessor will be blinded to group allocation throughout the study. The assessor will perform the baseline and post-intervention outcome measurements without knowing whether each participant has been allocated to the closed kinetic chain exercise with blood flow restriction group or the open kinetic chain exercise with blood flow restriction group. The physiotherapist providing the intervention and the participants will not be blinded due to the nature of the exercise interventions.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Knee osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1:  Closed kinetic chain exercises combined with blood flow restriction (CKC+BFR). Participants will receive a supervised 4-week rehabilitation program consisting of 3 sessions per week (12 sessions in total). The closed kinetic chain exercise program will include squat-to-chair, step-up, and Swiss-ball leg press exercises. Blood flow restriction will be applied during exercise at 40–80% of the individually determined limb occlusion pressure (LOP). Exercises will be performed using a low load of 20–30% of one-repetition maximum (1RM), following a 30–15–15–15 repetition scheme with 30–40 seconds of rest between sets. Exercise load will be progressively increased according to participant tolerance while remaining within the prescribed low-load range. Each session will include a standardized warm-up consisting of 5 minutes of low-intensity stationary cycling or brisk walking followed by 2–3 minutes of gentle knee range-of-motion exercises. At the end of the session, participants will perform quadriceps and hamstring stretching, with each stretch held for 30 seconds and repeated twice. All sessions will be supervised by a licensed physiotherapist to ensure correct technique, safety, and adherence to the intervention protocol. Intervention 2: Intervention group 2: Open kinetic chain exercises combined with blood flow restriction (OKC+BFR). Participants will receive a supervised 4-week rehabilitation program consisting of 3 sessions per week (12 sessions in total). The open kinetic chain exercise program will include seated knee extension, straight leg raise, and hamstring curl exercises. Blood flow restriction will be applied during exercise at 40–80% of the individually determined limb occlusion pressure (LOP). Exercises will be performed using a low load of 20–30% of one-repetition maximum (1RM), following a 30–15–15–15 repetition scheme with 30–40 seconds of rest between sets. Exercise resistance will be progressively increased using external resistance such as ankle weights or elastic resistance bands according to participant tolerance while remaining within the prescribed low-load range. Each session will include a standardized warm-up consisting of 5 minutes of low-intensity stationary cycling or brisk walking followed by 2–3 minutes of gentle knee range-of-motion exercises. At the end of the session, participants will perform quadriceps and hamstring stretching, with each stretch held for 30 seconds and repeated twice. All sessions will be supervised by a licensed physiotherapist to ensure correct technique, safety, and adherence to the intervention protocol.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially sharable after unidentified individuals.

When:
Access period starts 3 months after the article is published.

To whom:
For researchers working in academic, scientific and hospital institutions.

Conditions:
Researchers working in the field of knee osteoarthritis and exercise therapy.

Where to obtain:
Applicants for documentation can contact Dr. Attarbashi Moghadam via email: attarbashi@sina.tums.ac.ir

How to obtain:
Once they have the necessary criteria, the information will be provided to them within a month.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Taqwa Salwan Alkhateeb</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Alkharkh</address>
        <city>Baghdad</city>
        <country1>Iraq</country1>
        <zip>10069</zip>
        <telephone>+964 781 294 2798</telephone>
        <email>taqwa98.ts@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Behrouz Attarbashi Moghadam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation, Piche Shemiran, Enghelab Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148965111</zip>
        <telephone>+98 21 7753 3939</telephone>
        <email>attarbashi@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iraq</country2>
      <country2>Iraq</country2>
      <country2>Iraq</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Adults aged 45–60 years.
Clinical and radiographic diagnosis of knee osteoarthritis, Kellgren–Lawrence grade II–III.
Body mass index (BMI) between 25–35 kg/m².
Knee pain intensity between 30–80 mm on a 100-mm Visual Analog Scale (VAS) during daily activities.
Mild to moderate lower limb malalignment, defined as varus or valgus deformity ≤10°.
Ability to walk independently with or without minimal assistive devices.
Willingness to participate and provide written informed consent.</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of total knee replacement surgery.
Intra-articular corticosteroid or hyaluronic acid injection within the past 3 months.
Uncontrolled hypertension, unstable angina, or recent myocardial infarction.
Peripheral vascular disease, history of deep vein thrombosis (DVT), or clotting disorders.
Neurological disorders affecting lower limb strength or mobility.
Contraindications to blood flow restriction training, such as severe varicosities, vascular insufficiency, or severe edema.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1:  Closed kinetic chain exercises combined with blood flow restriction (CKC+BFR). Participants will receive a supervised 4-week rehabilitation program consisting of 3 sessions per week (12 sessions in total). The closed kinetic chain exercise program will include squat-to-chair, step-up, and Swiss-ball leg press exercises. Blood flow restriction will be applied during exercise at 40–80% of the individually determined limb occlusion pressure (LOP). Exercises will be performed using a low load of 20–30% of one-repetition maximum (1RM), following a 30–15–15–15 repetition scheme with 30–40 seconds of rest between sets. Exercise load will be progressively increased according to participant tolerance while remaining within the prescribed low-load range. Each session will include a standardized warm-up consisting of 5 minutes of low-intensity stationary cycling or brisk walking followed by 2–3 minutes of gentle knee range-of-motion exercises. At the end of the session, participants will perform quadriceps and hamstring stretching, with each stretch held for 30 seconds and repeated twice. All sessions will be supervised by a licensed physiotherapist to ensure correct technique, safety, and adherence to the intervention protocol.</i_keyword>
      <i_keyword>Intervention group 2: Open kinetic chain exercises combined with blood flow restriction (OKC+BFR). Participants will receive a supervised 4-week rehabilitation program consisting of 3 sessions per week (12 sessions in total). The open kinetic chain exercise program will include seated knee extension, straight leg raise, and hamstring curl exercises. Blood flow restriction will be applied during exercise at 40–80% of the individually determined limb occlusion pressure (LOP). Exercises will be performed using a low load of 20–30% of one-repetition maximum (1RM), following a 30–15–15–15 repetition scheme with 30–40 seconds of rest between sets. Exercise resistance will be progressively increased using external resistance such as ankle weights or elastic resistance bands according to participant tolerance while remaining within the prescribed low-load range. Each session will include a standardized warm-up consisting of 5 minutes of low-intensity stationary cycling or brisk walking followed by 2–3 minutes of gentle knee range-of-motion exercises. At the end of the session, participants will perform quadriceps and hamstring stretching, with each stretch held for 30 seconds and repeated twice. All sessions will be supervised by a licensed physiotherapist to ensure correct technique, safety, and adherence to the intervention protocol.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: Before the intervention and after completion of the 12-session intervention. Method of measurement: Pain intensity will be measured using a 100-mm Visual Analogue Scale (VAS), ranging from 0 (no pain) to 100 (worst imaginable pain).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quadriceps muscle strength. Timepoint: Before the intervention and after completion of the 12 treatment sessions. Method of measurement: Quadriceps muscle strength will be measured using a handheld dynamometer.</sec_outcome>
      <sec_outcome>Physical function and symptoms related to knee osteoarthritis. Timepoint: Before the intervention and after completion of the 12 treatment sessions. Method of measurement: Measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-08-01</approval_date>
        <contact_name>Ethics Committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Mirkhani Street (East Nosrat), Tohid Square, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
